160 related articles for article (PubMed ID: 14277221)
1. [ON THE CLINICAL PICTURE OF CYTOSTATIC TREATMENT].
GROSS R
Anglo Ger Med Rev; 1964 Sep; 2():483-95. PubMed ID: 14277221
[No Abstract] [Full Text] [Related]
2. [PROBLEMS IN ACQUIRED RESISTANCE OF TUMORS TOWARDS CYTOSTATICS].
UJHAZY V
Bratisl Lek Listy; 1964; 44():562-8. PubMed ID: 14160201
[No Abstract] [Full Text] [Related]
3. [CYTOSTATIC THERAPY WITH ALKYLATING AGENTS FOR MALIGNANT TUMORS].
SCHUMACHER K; LANGE J
Dtsch Med J; 1964 Nov; 15():761-5. PubMed ID: 14329920
[No Abstract] [Full Text] [Related]
4. [COMPARATIVE STUDIES ON CYTOSTATIC ALKYLATING REACTIONS].
WEITZEL G; SCHNEIDER F; FRETZDORFF AM; SEYNSCHE K; FINGER H
Krebsforsch Krebsbekampf; 1964; 30():156-63. PubMed ID: 14283701
[No Abstract] [Full Text] [Related]
5. [Cytostatic agents].
Vos T
Pharm Weekbl; 1966 Feb; 101(5):100-2. PubMed ID: 5905180
[No Abstract] [Full Text] [Related]
6. THE CYTOSTATIC EFFECTS OF PYRIMIDINE COMPOUNDS.
MATTHIES E; PETERS JE
Can Res Suppl; 1963 Nov; ():1907-9. PubMed ID: 14080626
[No Abstract] [Full Text] [Related]
7. [CYTOSTATIC EFFECTS OF N-AND S-HYDROXYMETHYL AND N-C-N COMPOUNDS].
WEITZEL G; SCHNEIDER F; FRETZDORFF AM; SEYNSCHE K; FINGER H
Z Naturforsch B; 1963 Dec; 18():1121-2. PubMed ID: 14120068
[No Abstract] [Full Text] [Related]
8. [Cytostatic agents and cytostatic therapy].
Host H
Tidsskr Nor Laegeforen; 1973 Sep; 93(26):1857-62. PubMed ID: 4767918
[No Abstract] [Full Text] [Related]
9. [The rational use of cytostatic agents].
Zwaveling A
Ned Tijdschr Geneeskd; 1969 Oct; 113(41):1795-801. PubMed ID: 5344635
[No Abstract] [Full Text] [Related]
10. Rational use of cancer chemotherapeutic agents. I. Antimetabolites and alkylating agents.
SEXTON RC
J Tn State Med Assoc; 1962 Mar; 55():91-6. PubMed ID: 13911019
[No Abstract] [Full Text] [Related]
11. [ON THE CARCINOSTATIC EFFECTS OF AMINOALKYLATING COMPOUNDS. 1. ON CYTOSTATICS].
SCHOENENBERGER H; ADAM A
Arzneimittelforschung; 1964 Oct; 14():1168. PubMed ID: 14343486
[No Abstract] [Full Text] [Related]
12. [Cytostatics in gynecologic neoplastic diseases].
VASTERLING HW
Dtsch Med J; 1963 May; 14():289-93. PubMed ID: 13996456
[No Abstract] [Full Text] [Related]
13. [ON INHIBITION OF ANTIBODY FORMATION BY CORTICOSTEROIDS AND CYTOSTATICS. (I)].
FRENGER W; WOLLENSAK J; HENNING N; EL-HASSAN A
Med Welt; 1965 Apr; 17():920-4 CONTD. PubMed ID: 14293909
[No Abstract] [Full Text] [Related]
14. [DETERMINATION OF THE CYTOTOXIC EFFECT OF DIFFERENT INHIBITORS AND CYTOSTATICS ON TISSUE CULTURE].
HORAKOVA K
Biologia (Bratisl); 1965; 20():189-93. PubMed ID: 14318513
[No Abstract] [Full Text] [Related]
15. [Basic principles and clinical pharmacology of cytostatic treatment].
Schmidt CG
Verh Dtsch Ges Inn Med; 1980; 86():337-67. PubMed ID: 7223027
[No Abstract] [Full Text] [Related]
16. [THE VALUE OF ANTINEOPLASTIC CHEMOTHERAPY IN THE ADVANCED PHASES OF THE DISEASE].
GARDINI GF
Bull Sci Med (Bologna); 1964; 136():143-50. PubMed ID: 14167447
[No Abstract] [Full Text] [Related]
17. [Pulmonary changes caused by cytostatic drugs].
Akoun G; Milleron B; Mayaud C
Ann Med Interne (Paris); 1985; 136(8):671-6. PubMed ID: 3914227
[TBL] [Abstract][Full Text] [Related]
18. [Cytostatic treatment of malignant blood dyscrasias. (2). Pharmacology].
Diamant B
Lakartidningen; 1967 May; 64():Suppl 2:33-7 p. PubMed ID: 5585563
[No Abstract] [Full Text] [Related]
19. [DPN content, nucleic acid content and cell structure of ascites tumor cells after administration of alkylating cytostatics].
DOLD U; MIELSCH M; HOLZER H
Z Krebsforsch; 1962; 65():139-46. PubMed ID: 14028420
[No Abstract] [Full Text] [Related]
20. Chromosomal aberration due to cytostatic agents.
Stacher A; Novotny H; Ruzicka F; Schuhfried G
Int J Clin Pharmacol; 1974 Jun; 9(4):250-7. PubMed ID: 4422172
[No Abstract] [Full Text] [Related]
[Next] [New Search]
